4.7 Review

The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Related references

Note: Only part of the references are listed.
Letter Medicine, General & Internal

Resolution of severe digital ulceration during a course of bosentan therapy

MJ Snyder et al.

ANNALS OF INTERNAL MEDICINE (2005)

Article Medicine, Research & Experimental

Collecting duct-specific knockout of endothelia-1 causes hypertension and sodium retention

D Ahn et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Cardiac & Cardiovascular Systems

Hypertension induced by blockade of ETB receptors in conscious nonhuman primates:: role of ETA receptors

GA Reinhart et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)

Article Physiology

Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats

DD Ivy et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)

Article Cardiac & Cardiovascular Systems

Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious rats

AJ Trapani et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)